Vanda Pharmaceuticals, Inc. (VNDA)
5.43
+0.09
(+1.69%)
USD |
NASDAQ |
Sep 04, 16:00
5.43
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Max Drawdown (5Y) : 89.26% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 89.26% |
| July 31, 2026 | 89.26% |
| June 30, 2026 | 89.26% |
| May 31, 2026 | 89.26% |
| April 30, 2026 | 89.26% |
| March 31, 2026 | 89.26% |
| February 28, 2026 | 89.26% |
| January 31, 2026 | 89.26% |
| December 31, 2025 | 89.26% |
| November 30, 2025 | 89.26% |
| October 31, 2025 | 89.26% |
| September 30, 2025 | 89.26% |
| August 31, 2025 | 89.26% |
| July 31, 2025 | 89.26% |
| June 30, 2025 | 89.26% |
| May 31, 2025 | 89.26% |
| April 30, 2025 | 89.26% |
| March 31, 2025 | 89.26% |
| February 28, 2025 | 89.26% |
| January 31, 2025 | 89.26% |
| December 31, 2024 | 89.26% |
| November 30, 2024 | 89.26% |
| October 31, 2024 | 89.26% |
| September 30, 2024 | 89.26% |
| August 31, 2024 | 89.26% |
| Date | Value |
|---|---|
| July 31, 2024 | 89.26% |
| June 30, 2024 | 89.26% |
| May 31, 2024 | 89.26% |
| April 30, 2024 | 89.26% |
| March 31, 2024 | 89.26% |
| February 29, 2024 | 89.26% |
| January 31, 2024 | 89.26% |
| December 31, 2023 | 89.26% |
| November 30, 2023 | 89.26% |
| October 31, 2023 | 86.88% |
| September 30, 2023 | 86.40% |
| August 31, 2023 | 83.51% |
| July 31, 2023 | 81.63% |
| June 30, 2023 | 81.25% |
| May 31, 2023 | 81.09% |
| April 30, 2023 | 80.49% |
| March 31, 2023 | 80.36% |
| February 28, 2023 | 79.54% |
| January 31, 2023 | 78.17% |
| December 31, 2022 | 78.17% |
| November 30, 2022 | 76.17% |
| October 31, 2022 | 76.17% |
| September 30, 2022 | 76.17% |
| August 31, 2022 | 76.17% |
| July 31, 2022 | 76.17% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Protagonist Therapeutics, Inc. | 85.79% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 96.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -29.82 |
| Beta (5Y) | 0.6446 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 45.93% |
| Historical Sharpe Ratio (5Y) | -0.5219 |
| Historical Sortino (5Y) | -0.9655 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.56% |